Treatment (Meds) Veterinary Evidence-Based

Claritin for Dogs: Safe Loratadine Dosage, Uses & Comparison

Claritin (active ingredient: loratadine) is another popular, non-drowsy second-generation antihistamine used in veterinary medicine. It blocks peripheral histamine H1 receptors, helping alleviate mild environmental allergy symptoms, facial itching, and hives from bee stings.

0.1 - 0.25 mg/lb
Canine Dosage
Typically 5 mg for small dogs, 10 mg for medium/large dogs
Extremely Low
Sedation Risk
Does not readily cross the blood-brain barrier
NO Claritin-D
FATAL WARNING
Contains lethal pseudoephedrine decongestant

Claritin (Loratadine) Dosage Guidelines for Dogs

Dog Size / WeightTypical Veterinary Reference Range (Confirm with Your Vet)FormFrequency
Small Dogs (Under 15 lbs)2.5 – 5 mg1/2 of 5mg or 1/2 of 10mg tabletOnce daily
Medium Dogs (15 – 40 lbs)5 – 10 mgOne 5mg or 10mg tabletOnce daily
Large Dogs (Over 40 lbs)10 mgOne 10mg tabletOnce daily (or every 12h per vet)

CRITICAL WARNING: Never Give Claritin-D (Pseudoephedrine Toxicity)

Claritin-D contains pseudoephedrine, a potent decongestant formulated for humans that is extremely toxic and frequently fatal to dogs. Ingestion of pseudoephedrine triggers massive adrenergic stimulation, causing severe hypertension, tachycardia, tremors, seizures, and cardiovascular collapse within hours. Always verify your packaging states ONLY pure Loratadine without added decongestants.

Frequently Asked Questions

Which works better for dogs: Claritin or Zyrtec?
Clinical veterinary experience generally finds Zyrtec (cetirizine) slightly more effective for canine skin pruritus than Claritin (loratadine). However, every dog's individual receptor response differs. If your dog does not respond to Claritin after 14 days, your vet may recommend switching to cetirizine or a targeted prescription treatment.
Related Canine Allergy Decision Pillars
Allergy Topic Hub

Central portal linking all 5 clusters and testing methodologies.

Topic Hub

Evidence-Based Veterinary References

  1. Cosgrove, S. B., Wren, J. A., Cleaver, D. M., et al. (2013). Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Veterinary Dermatology, 24(5), 479-e114. [View Reference]
  2. Moyaert, H., Van Brussel, L., Borowski, S., et al. (2017). A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to cyclosporine in dogs with atopic dermatitis. Veterinary Dermatology, 28(6), 593-e145. [View Reference]
  3. Merck Veterinary Manual. (2024). Allergies in Dogs. Merck Sharp & Dohme Corp. [View Reference]
  4. Today's Veterinary Practice. (2023). Canine Atopic Dermatitis Updates: Diagnosis & Treatment. NAVC Publications. [View Reference]